1h Free Analyst Time
The publisher has been monitoring the biobanking market and it is poised to grow by $ 1.28 bn during 2021-2025, progressing at a CAGR of 8.44% during the forecast period. The report on the biobanking market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for personalized medicine and increase in efficiency through automation will increase demand.
The biobanking market analysis includes the product segment and geographic landscape.
The biobanking market is segmented as below:
By Product
- Equipment
- Consumables
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the reduction in research costs as one of the prime reasons driving the biobanking market growth during the next few years.
The report on biobanking market covers the following areas:
- Biobanking market sizing
- Biobanking market forecast
- Biobanking market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biobanking market vendors that include AMS Biotechnology (Europe) Ltd., ASKION GmbH, Bay Biosciences LLC, Cureline Inc., Firalis SA, GENETICIST Inc., Hamilton Bonaduz AG, ProteoGenex Inc., Thermo Fisher Scientific Inc., and US Biolab Corp. Inc. Also, the biobanking market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Equipment - Market size and forecast 2020-2025
- Consumables - Market size and forecast 2020-2025
- Market opportunity by Product
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AMS Biotechnology (Europe) Ltd.
- ASKION GmbH
- Bay Biosciences LLC
- Cureline Inc.
- Firalis SA
- GENETICIST Inc.
- Hamilton Bonaduz AG
- ProteoGenex Inc.
- Thermo Fisher Scientific Inc.
- US Biolab Corp. Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Product - Market share 2020-2025 (%)
- Comparison by Product
- Equipment - Market size and forecast 2020-2025 ($ million)
- Equipment - Year-over-year growth 2020-2025 (%)
- Consumables - Market size and forecast 2020-2025 ($ million)
- Consumables - Year-over-year growth 2020-2025 (%)
- Market opportunity by Product
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- AMS Biotechnology (Europe) Ltd. - Overview
- AMS Biotechnology (Europe) Ltd. - Product and service
- AMS Biotechnology (Europe) Ltd. - Key offerings
- AMS Biotechnology (Europe) Ltd. - Key customers
- AMS Biotechnology (Europe) Ltd. - Segment focus
- ASKION GmbH - Overview
- ASKION GmbH - Product and service
- ASKION GmbH - Key offerings
- ASKION GmbH - Key customers
- ASKION GmbH - Segment focus
- Bay Biosciences LLC - Overview
- Bay Biosciences LLC - Product and service
- Bay Biosciences LLC - Key offerings
- Bay Biosciences LLC - Key customers
- Bay Biosciences LLC - Segment focus
- Cureline Inc. - Overview
- Cureline Inc. - Product and service
- Cureline Inc. - Key offerings
- Cureline Inc. - Key customers
- Cureline Inc. - Segment focus
- Firalis SA - Overview
- Firalis SA - Product and service
- Firalis SA - Key offerings
- Firalis SA - Key customers
- Firalis SA - Segment focus
- GENETICIST Inc. - Overview
- GENETICIST Inc. - Product and service
- GENETICIST Inc. - Key offerings
- GENETICIST Inc. - Key customers
- GENETICIST Inc. - Segment focus
- Hamilton Bonaduz AG - Overview
- Hamilton Bonaduz AG - Product and service
- Hamilton Bonaduz AG - Key offerings
- Hamilton Bonaduz AG - Key customers
- Hamilton Bonaduz AG - Segment focus
- ProteoGenex Inc. - Overview
- ProteoGenex Inc. - Product and service
- ProteoGenex Inc. - Key offerings
- ProteoGenex Inc. - Key customers
- ProteoGenex Inc. - Segment focus
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Key customers
- Thermo Fisher Scientific Inc. - Segment focus
- US Biolab Corp. Inc. - Overview
- US Biolab Corp. Inc. - Product and service
- US Biolab Corp. Inc. - Key offerings
- US Biolab Corp. Inc. - Key customers
- US Biolab Corp. Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global biobanking market: AMS Biotechnology (Europe) Ltd., ASKION GmbH, Bay Biosciences LLC, Cureline Inc., Firalis SA, GENETICIST Inc., Hamilton Bonaduz AG, ProteoGenex Inc., Thermo Fisher Scientific Inc., and US Biolab Corp. Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is reduction in research costs.`
According to the report, one of the major drivers for this market is the growing demand for personalized medicine.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- AMS Biotechnology (Europe) Ltd.
- ASKION GmbH
- Bay Biosciences LLC
- Cureline Inc.
- Firalis SA
- GENETICIST Inc.
- Hamilton Bonaduz AG
- ProteoGenex Inc.
- Thermo Fisher Scientific Inc.
- US Biolab Corp. Inc.